Hematological Findings and Alteration of Oxidative Stress Markers in Hospitalized Patients with SARS-COV-2

Kalina Gjorgjievska1, Marija Petrushevska1, Dragica Zendelovska1

  • 1University of Ss Cyril and Methodius, Faculty of Medicine, Institute of Preclinical and Clinical Pharmacology and Toxicology, Skopje, RN Macedonia.

Insights

Oxidative stress markers effectively indicate COVID-19 disease progression. These markers correlate with D-dimer, neutrophil to lymphocyte ratio, and platelet to lymphocyte ratio, offering an accessible tool for severity classification.

Area of Science:

  • Biochemistry
  • Hematology
  • Immunology

Background:

  • Hematological parameters are crucial for COVID-19 severity assessment.
  • Oxidative stress plays a significant role in disease progression.
  • D-dimer, NLR, and PLR are established markers for COVID-19 severity.

Purpose of the Study:

  • To analyze oxidative stress in hospitalized COVID-19 patients.
  • To determine the association between oxidative stress markers and D-dimer, NLR, and PLR.
  • To evaluate oxidative stress as a marker for COVID-19 disease progression.

Main Methods:

  • 52 moderate to severe COVID-19 patients were enrolled.
  • Hematological and coagulation profiles were analyzed.
  • Serum PAT (total antioxidant power) and d-ROMs (plasma peroxides) were measured at admission and 7 days post-hospitalization.

Main Results:

  • Severe COVID-19 cases showed parameters indicating poor prognosis.
  • Recovered patients exhibited reduced d-ROMs and improved oxidative stress index.
  • Deceased patients had decreased PAT, signifying increased oxidative stress.
  • A strong correlation was observed between oxidative stress markers and D-dimer, PLR, and NLR (p<0.01), with exceptions noted.

Conclusions:

  • Oxidative stress markers serve as a valuable tool for monitoring COVID-19 progression.
  • These markers offer an accessible and affordable addition to conventional severity classification methods.
  • Oxidative stress assessment aids in understanding disease severity and patient outcomes.